California

Clarification: Amylin FDA info request story

SAN DIEGO - In a story March 15, The Associated Press reported that Bydureon is the proposed trade name of exenatide, a diabetes treatment being developed by Amylin Pharmaceuticals Inc., Eli Lilly & Co.

MORE..

Halozyme takes bigger loss on testing expenses

SAN DIEGO - Biotechnology company Halozyme Therapeutics Inc.

MORE..

Biocon limited, Amylin pharmaceuticals enter global development agreement

BANGALORE/ CALIFORNIA - Biocon, Limited (NSE: BIOCON) and Amylin Pharmaceuticals, Inc.

MORE..

Older News
S	M	T	W	T	F	S
24	25	26	27	28	29	30
31	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy